Lung Disease Therapeutics Market Revenue 2024 to 2034
Lung Disease Therapeutics Market Revenue 2024 to 2034
The global lung disease therapeutics market size is projected to reach USD 165.17 billion by 2034, growing from USD 96.94 billion in 2025, at a CAGR of 6.1% during the forecast period from 2025 to 2034, as a result of rising advancement in targeted and personalized therapies and increasing prevalence of associated diseases.
Report ID: 10099
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 91.36 Bn
Forecast Year,
USD USD 165.17 Bn
CAGR, 2025 -
6.1%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Lung Disease Therapeutics Market Size Analysis
Lung Disease Therapeutics Market Size By Disease Type 2024 to 2034 (USD )
| Disease Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asthma | 31.98 | 34.02 | 36.20 | 38.52 | 40.98 | 43.61 | 46.40 | 49.37 | 52.52 | 55.88 | 59.46 |
| Lung Cancer | 36.54 | 38.72 | 41.04 | 43.48 | 46.08 | 48.83 | 51.74 | 54.83 | 58.10 | 61.57 | 65.24 |
| Chronic Obstructive Pulmonary Disease (COPD) | 22.84 | 24.18 | 25.61 | 27.12 | 28.71 | 30.40 | 32.19 | 34.09 | 36.09 | 38.22 | 40.46 |
Lung Disease Therapeutics Market Size By Drug Class 2024 to 2034 (USD )
| Drug Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corticosteroids | 22.84 | 24.28 | 25.81 | 27.44 | 29.18 | 31.02 | 32.97 | 35.05 | 37.27 | 39.62 | 42.12 |
| Bronchodilator | 18.27 | 19.44 | 20.67 | 21.99 | 23.39 | 24.87 | 26.46 | 28.14 | 29.93 | 31.83 | 33.86 |
| Antimicrobial | 16.44 | 17.42 | 18.45 | 19.54 | 20.70 | 21.93 | 23.23 | 24.60 | 26.06 | 27.60 | 29.23 |
| Alkylating Agents | 20.10 | 21.29 | 22.54 | 23.88 | 25.29 | 26.78 | 28.36 | 30.03 | 31.81 | 33.69 | 35.67 |
| Mucolytics | 13.70 | 14.51 | 15.37 | 16.27 | 17.23 | 18.24 | 19.32 | 20.45 | 21.66 | 22.93 | 24.28 |
Lung Disease Therapeutics Market Size By Molecule Type 2024 to 2034 (USD )
| Molecule Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small molecules | 59.38 | 62.91 | 66.64 | 70.60 | 74.79 | 79.23 | 83.93 | 88.91 | 94.19 | 99.78 | 105.70 |
| Biologics | 31.98 | 34.02 | 36.20 | 38.52 | 40.98 | 43.61 | 46.40 | 49.37 | 52.52 | 55.88 | 59.46 |
Lung Disease Therapeutics Market Size By Treatment Type 2024 to 2034 (USD )
| Treatment Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemotherapy | 27.41 | 29.03 | 30.75 | 32.57 | 34.50 | 36.54 | 38.71 | 41.00 | 43.43 | 46.00 | 48.72 |
| Immunotherapy | 18.27 | 19.44 | 20.67 | 21.99 | 23.39 | 24.87 | 26.46 | 28.14 | 29.93 | 31.83 | 33.86 |
| Targeted Therapy | 31.98 | 33.96 | 36.06 | 38.29 | 40.66 | 43.18 | 45.85 | 48.69 | 51.70 | 54.90 | 58.30 |
| Radiation Therapy | 13.70 | 14.51 | 15.37 | 16.27 | 17.23 | 18.24 | 19.32 | 20.45 | 21.66 | 22.93 | 24.28 |
Lung Disease Therapeutics Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Online | 13.70 | 14.64 | 15.63 | 16.70 | 17.83 | 19.04 | 20.33 | 21.71 | 23.18 | 24.75 | 26.43 |
| Hospital | 50.25 | 53.22 | 56.36 | 59.69 | 63.21 | 66.95 | 70.90 | 75.09 | 79.52 | 84.22 | 89.19 |
| Retail | 27.41 | 29.08 | 30.85 | 32.74 | 34.73 | 36.85 | 39.10 | 41.48 | 44.01 | 46.70 | 49.55 |
Lung Disease Therapeutics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 36.54 | 38.68 | 40.93 | 43.32 | 45.85 | 48.52 | 51.35 | 54.34 | 57.51 | 60.87 | 64.41 |
| Europe | 22.84 | 24.18 | 25.61 | 27.12 | 28.71 | 30.40 | 32.19 | 34.09 | 36.09 | 38.22 | 40.46 |
| Asia-Pacific | 18.27 | 19.48 | 20.77 | 22.15 | 23.62 | 25.18 | 26.85 | 28.62 | 30.52 | 32.53 | 34.68 |
| Latin America | 7.31 | 7.77 | 8.27 | 8.80 | 9.35 | 9.95 | 10.58 | 11.26 | 11.97 | 12.73 | 13.54 |
| Middle East & Africa | 6.40 | 6.81 | 7.26 | 7.74 | 8.24 | 8.78 | 9.36 | 9.97 | 10.62 | 11.32 | 12.06 |
Lung Disease Therapeutics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
